MAM and Other "Lesion" Models of Developmental Epilepsy

Models of Seizures and Epilepsy

Volumn , Issue , 2006, Pages 305-313

  Battaglia, Giorgio ^a   Bassanini, Stefania ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882867773     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088554-1/50025-6     Document Type: Chapter

References (59)

1. Ashwell K. Direct and indirect effects on the lateral geniculate nucleus neurons of prenatal exposure to methylazoxymethanol acetate. Dev Brain Res. 1987, 35:199-214.
2. Barahan S.C., Schwartzkroin P.A. Electrophysiology of CAI pyramidal neurons in an animal model of neuronal migration disorders: prenatal methylazoxymethanol treatment. Epilepsy Res 1995, 22:145-156.
3. Baraban S.C., Schwartzkroin P.A. Flurothyl seizure susceptibility in rats following prenatal methylazoxymethanol treatment. Epilepsy Res 1996, 23:189-194.
4. Baraban S.C., Wenzel H.J., Hochman D.W., Schwartzkroin P.A. Characterization of heterotopic cell clusters in the hippocampus of rats exposed to methylazoxymethanol in utero. Epilepsy Res 2000, 39:87-102.
5. Battaglia G., Arcelli P., Granata T., Selvaggio M.T., Andermann F., Dubeau F., Olivier A., et al. Neuronal migration disorders and epilepsy: a morphological analysis of three surgically trated patients. Epilepsy Res. 1996, 26:49-58.
6. Battaglia G., Granata T., Farina L., D'Incerti L., Franceschetti S., Avanzini G. Periventricular nodular Heterotopia: epileptogenic findings. Epilepsia 1997, 38:1173-1182.
7. Battaglia G., Pagliardini S., Ferrario A., Gardoni F., Tassi L., Setola V., Garbelli R., et al. AlphaCaMKII and NMDA-receptor subunit expression in epileptogenic cortex from human periventricular nodular heterotopia. Epilepsia. 2002, 43:209-216.
8. Battaglia G., Pagliardini S., Saglietti L., Cattabeni F., Di Luca M., Bassanini S., Setola V. Neurogenesis in cerebral heterotopia induced in rats by prenatal methylazoxymethanol treatment. Cereb Cortex 2003, 13:736-748.
9. Battaglia G., Bassanini S., Granata T., Setola V., Giavazzi P., Pagliardini S. The genesis of epileptogenic cerebral heterotopia: clues from experimental models. Epileptic Disord 2003, 5(Suppl 2):S51-S58.
10. Bayer S.A., Altman J., Russo R.J., Zhang X. Time tables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology 1993, 14:83-144.
11. Benardete E.A., Kriegstein A.R. Increased excitability and decreased sensitivity to GABA in an animal model of dysplastic cortex. Epilepsia 2002, 43:970-982.
12. Calcagnotto M.E., Paredes M.F., Baraban S.C. Heterotopic neurons with altered inhibitory synaptic function in an animal model of malformation-associated epilepsy. J Neurosci 2002, 22:7596-7605.
13. Castro P.A., Cooper E.C., Lowenstein D.H., Baraban S.C. Hippocampal heterotopia lack functional Kv4.2 potassium channels in the methylazoxymethanol model of cortical malformations and epilepsy. J Neurosci. 2001, 21:6626-6634.
14. Cattabeni F., Di Luca M. Developmental models of brain dysfunctions induced by targeted cellular ablations with methylazoxymethanol. Physiol Rev. 1997, 77:199-215.
15. Cattaneo E., Reinach B., Caputi A., Cattabeni F., Di Luca M. Selective in vitro blockade of neuroepithelial cells proliferation by methylazoxymethanol a molecule capable of inducing long lasting functional impaiments. J Neurosci Res 1995, 41:640-647.
16. Chevassus-Au-Louis N., Rafiki A., Jorquera I., Ben-Ari Y., Represa A. Neocortex in the hippocampus: an anatomical and functional study of CA1 heterotopias after prenatal treatment with methylazoxymethanol in rats. J Comp Neuro 1998, 394:520-536.
17. Chevassus-Au-Louis N., Congar P., Represa A., Ben-Ari Y., Gaiarsa J.L. Neuronal migration disorders: heterotopic neocortical neurons in CA1 provide a bridge between the hippocampus and the neocortex. Proc Natl Acad Sci 1998, 95:10263-10268.
18. Chevassus-Au-Louis N., Baraban S.C., Gaiarsa J.L., Ben-Ari Y. Cortical malformations and epilepsy: new insights from animal models. Epilepsia. 1999, 40:811-821.
19. Colacitti C., Sancini G., Franceschetti S., Cattabeni F., Avanzini G., Spreafico R., Di Luca M., et al. Altered connections between neocortical and heterotopic areas in methylazoxymethanol-trated-rats. Epilepsy Res. 1998, 32:49-62.
20. Colacitti C., Sancini G., DeBiasi S., Franceschetti S., Caputi A., Frassoni C., Cattabeni F., et al. Prenatal methylazoxymethanoltratment in rats produces brain abnormalities with morphological similarities to hulam developmental brain dysgeneses. J Neuropathol Exp Neurol. 1999, 58:92-106.
21. Collier P.A., Ashwell K.W. Distribution of neuronal heterotopiae following prenatal exposure to methylazoxymethanol. J Neurotoxicol Teratol. 1993, 15:439-444.
22. Dambska M., Haddad R., Kozlowski P.B., Lee M.H., Shek J. Telencephalic cytoarchitectonis in the brains of rats with graded degrees of microencephaly. Acta Neuropathol. 1982, 58:203-209.
23. De Feo M.R., Mecarelli O., Ricci G.F. Seizure susceptibility in immaure rats with microencephaly induced by prenatal exposure to methylazoxymethanol acetate. Pharmacol Res 1995, 31:109-114.
24. Druckrey H., Ivankovic S., Preussmann R. Teratogenic and carcinogenic effects in the offspring after single injection of ethylnitrosurea to pregnant rats. Nature (Lond) 1966, 210:1378-1379.
25. Dvorak K., Feit J., Jurankova Z. Experimentally induced focal microgyria and status verucosus deformis in rats: pathogenesis and interrelation histological and autoradiographical study. Acta Neurophathol 1978, 44:121-129.
26. Gardoni F., Pagliardini S., Setola V., Bassanini S., Cattabeni F., Battaglia G., Di Luca M. The NMDA receptor complex is altered in an animal model of human cerebral heterotopia. J. Neuropathol Exp Neurol 2003, 62:662-675.
27. Germano I.M., Sperber E.F. Increased seizure susceptibility in adult rats with neuronal migration disorders. Brain Res 1997, 777:219-222.
28. Gombar C.T., Tong W.P., Ludlum D.B. Mechanism of action of the nitrosoureas-IV. Reactions of bis-chloroethyl nitrosourea and chloroethyl cyclohexyl nitrosourea with deoxyribonucleic acid. Biochem Pharmacol 1980, 29:2639-2643.
29. Guerrini R., Sicca F., Parmeggiani L. Epilepsy and malformations of the cerebral cortex. Epileptic Disord. 2003, 5:9-26.
30. Gutova M., Elis J., Raskova Transfer of 6-azauridine through the placental barrier in the rat. Neoplasma 1971, 18:529-531.
31. Haddad R.K., Rabe A., Laqueur G.L., Spatz M., Valsamis M.P. Intellectual deficit associated with transplacentally induced microcephaly in the rat. Science 1969, 163:88-90.
32. Haddad R.K., Rabe A., Dumas R. Comparison of effects of methylazoxymethanol acetate on brain development in different species. Federation Proc. 1972, 31:1520-1523.
33. Hallas B.H., Das G.D. N-ethyl-N-nitrosourea-induced teratogenesis of brain in the rat. A cellular and cytoarchitectural analysis of the neocortex. J Neurol Sci 1978, 39:111-122.
34. Hicks S.P., D'Amato C.J., Lowe M.J. The development of mammalian nervous system: I. Malformation of the brain, especially the cerebral cortex, induced in rats by radiation. II. Some mechanisms of the malformations of the cortex. J Comp Neurol 1959, 113:435-469.
35. Inouye M., Kajiwara Y. Developmental disturbances of the fetal brain in guinea-pigs caused by methylmercury. Arch Toxicol. 1988, 62:15-21.
36. Johnston M.V., Coyle J.T. Histological and neurochemical effects of foetal treatment with methylazoxymethanol on rat neocortex in adulthood. Brain Res. 1979, 170:135-155.
37. Johnston M.V., Coyle J.T. Cytotoxic lesions and the development of transmitter systems. Trends Neurosci. 1982, 5:153-156.
38. Kisby G.E., Ellison M., Spencer P.S. Content of the neurotoxins cycasin and BMAA in cycad flour prepared by Guam Chamorros. Neurology 1992, 42:1336-1340.
39. Matsumoto H., Strong F.M. The occurrence of methylazoxymethanol in Cycas Circinalis L. Arch Biochem Biophys. 1963, 101:299-310.
40. Matsumoto H., Spatz M., Laqueur G.L. Quantitative changes with age in the DNA content of MAM-induced microencephalic rat brain. J Neurochem. 1972, 19:297-306.
41. Matsumoto H., Koya G., Takeuschi T. Fetal Minamata disease. A Neuropathological study of two cases of intrauterine intoxication by methyl mercury compound. J. Neuropathol Exp Neurol 1975, 24:563-574.
42. Pinto A., Zagonel V. 5-Aza-2′-deoxycytidine (Decitabine) and 5-azacytidine in the treatment of acute myeloid leukemias and myelodysplastic syndromes: past, present and future trends. Leukemia 1993, 7:51-60.
43. Ramakers M.J., Urban I.J.A., De Graan P.N.E., di Luca M., Cattabeni F., Gispen W.H. The impaired long-term potentiation in the CA1 field of the hippocampus of cognitive deficient microencephalic rats is restored by D-serine. Neuroscience 1993, 54:49-60.
44. Rodier P.M. Correlations between prenatally-induced alterations in CNS cell populations and post-natal function. Teratology 1977, 16:235-246.
45. Rodier P.M., Reynolds S.S. Morphological correlates of behavioural abnormalities in experimental congenital brain damage. Exp Neurol 1977, 57:81-93.
46. Rodier P.M. Differential structural effects of three behavioral teratogens. Dev Toxicol Environ Sci. 1983, 11:53-60.
47. Rodier P.M. Differential structural effects of three behavioral teratogens. Dev Toxicol Environ Sci. 1983, 11:53-60.
48. Rodier P.M. Behavioral effects of antimitotic agents administered during neurogenesis. Handbook of Behavioral Teratology 1986, 185-209. Plenum, New York. E.P. Riley, C.V. Vorhees (Eds.).
49. Rodier P.M. Developmental neurotoxicology. Toxicol Pathol 1990, 18(1 Pt 2):89-95.
50. Roper S.N., Abraham L.A., Streit W.J. Exposure in utero irradiation produces disruption of radial glia in rats. Dev Neurosci. 1997, 19:521-528.
51. Sancini G., Franceschetti S., Battaglia G., Colacitti C., Di Luca M., Spreafico R., Avanzini G. Dysplastic neocortex and subcortical heterotopias in methylazoxymethanol-treated rats: an intracellular study of identified pyramidal neurones. Neurosci Lett 1998, 246:181-185.
52. Seifertova M., Vesely J., Sorm F. Effect of 5-azacytidine on developing mouse embryo. Experientia 1968, 24:487-488.
53. Seifertova M., Vesely J., Cilhak A. Localization of the labelled 5-azacytidine in cultured mouse embryonic cells. Experientia 1974, 30:1463-1465.
54. Singh SC. Ectopic neurones in the hippocampus of postnatal rat exposed in utero to methylazoxymethanol duriing foetal development. Acta Neuropathol. 1977, 40:111-116.
55. Sorm T.J., Piskala A., Cihak A. 5-Azacytidine, a new highly effective cancerostatic. Experientia 1964, 20:202-203.
56. Tamaru M., Hirata Y., Nagayoshi M., Matsutani T. Brain changes in rats induced by prenatal injection of methylazoxymethanol. Teratology 1988, 37:149-157.
57. Taylor S.M., Jones P.A. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 1979, 17:771-779.
58. Vorhees C.V., Fernandez K., Dumas R.M., Haddad R.K. Pervasive hyperactivity and long-term impairment in rats with induced microencephaly from prenatal exposure to Methylazoxymethanol. Develop Brain Res 1984, 15:1-10.
59. Whiting M.G. Toxicity of cycads. Economic Botany 1963, 17:271.